Lipid Optimisation- Management of LDL-C: Are Statins Enough? This promotional symposium has been organised and funded by Daiichi Sankyo UK Ltd where medicines will be discussed and is intended for UK HCPs only
LIVE STREAM OPTION: Standard of Care in Type 2 Diabetes Management
This meeting has been organised by CliniLink Ltd and is supported by the pharmaceutical industry via the purchase of exhibition stands. The sponsoring companies AbbVie, Androlabs, Ascensia Diabetes Care, Besins Healthcare, Neon Diagnostics, Pfizer and TriOn Pharma have had no involvement in the development of the agenda or content of this meeting.
Lipid Optimisation- Management of LDL-C: Are Statins Enough? This promotional symposium has been organised and funded by Daiichi Sankyo UK Ltd where medicines will be discussed and is intended for UK HCPs only
See Sponsors below
LIVE STREAM EVENT
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: Online
This is the live stream alternative to the face to face London event
Deep Dive: Standard Of Care in Type 2 Diabetes Management
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 09:50-10:00 | Registration & Introduction | |
| 10:00-11:00 | Getting the Diagnosis Right This session covers diabetes diagnosis (HbA1c, fasting glucose, OGTT) with key pitfalls, differentiation of Type 2 from LADA, MODY, Type 1 and secondary diabetes, the role of autoantibodies, C-peptide and red flags, risk stratification and high-risk phenotypes, plus sex-specific considerations in women (PCOS, gestational diabetes, menopause) and screening for hypogonadism in men. | Prof. Saqib Mahmud |
| 11:00-11:30 | Break | |
| 11:30-12:30 | Prevention, Early Intervention & Holistic Assessment This session covers preventing diabetes progression through lifestyle and pharmacological strategies, the legacy effect, comprehensive risk assessment (cardiovascular, renal, liver and microvascular), including eye disease screening and treatment, addressing health inequalities, and women’s health across the life course—including menopause-related cardio-renal-metabolic risk | Prof. Saqib Mahmud |
| 12:30-13:30 | LUNCH/ Networking | |
| 13:30-14:15 | Break | |
| 14:15-14:30 | Event sponsors | Event Sponsors |
| 14:30-15:00 | Break | |
| 15:00-16:00 | Modern Glycaemic Management This session covers individualising HbA1c targets, early combination therapy and avoiding therapeutic inertia, optimal use of metformin, SGLT2 inhibitors and GLP-1 receptor agonists, a weight-centric approach, confident insulin initiation, cardio-renal protection—particularly in women through menopause—and guideline-based management of hypogonadism in men with Type 2 diabetes. | Prof. Saqib Mahmud |
Meet the Speaker
Professor Saqib Mahmud
FRCP (Edin) FRCP (Glasg) FRCP (London) FRCGPProfessor Saqib Mahmud specialises in all aspects of diabetes with its complexities and co-morbidities. He is passionate about preventing diabetes associated complications and prevention of strokes and heart attacks by early intervention in diabetes and providing a legacy effect which will prevent complications in the future. Diabetes lead at his practice since 2005, he has spent 15 years raising clinical standards, teaching healthcare professionals and junior doctors, and refining his expertise at international congresses. He also serves as a certified diabetes educator and Early Action in Diabetes UK champion
Symposium Sponsor
Event Sponsors
This meeting has been organised by CliniLink Ltd and is supported by the pharmaceutical industry via the purchase of exhibition stands. The sponsoring companies AbbVie, Androlabs, Ascensia Diabetes Care, Besins Healthcare, Neon Diagnostics, Pfizer and TriOn Pharma have had no involvement in the development of the agenda or content of this meeting.
